Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progression after chronic manganese exposure

C C Huang1, C S Lu, N S Chu

  • 1Department of Neurology, Chang Gung Medical College and Memorial Hospital, Taipei, Taiwan.

Neurology
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The object technology framework: an object-oriented interface to molecular data and its application to collagen.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·1998
Same author

Oxygen, arterial blood gases and ventilation are unchanged during dialysis in patients receiving pressure support ventilation.

Respiratory medicine·1998
Same author

Perinatal hypoxic/ischemic encephalopathy: clinical challenge and experimental implications.

Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui·1998
Same author

Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan.

Journal of toxicology and environmental health. Part A·1998
Same author

Subdural empyema in 10 infants: US characteristics and clinical correlates.

Radiology·1998
Same author

X-linked recessive bulbospinal neuronopathy: clinical and molecular studies in a Taiwanese family.

Journal of the Formosan Medical Association = Taiwan yi zhi·1998

Chronic manganese exposure causes parkinsonism with progressive symptoms, even after exposure stops. Levodopa treatment offers limited, temporary relief in these patients.

Area of Science:

  • Neurology
  • Environmental Health
  • Toxicology

Background:

  • Manganese exposure can lead to parkinsonism, a neurological disorder.
  • Longitudinal studies are crucial for understanding disease progression after exposure cessation.

Purpose of the Study:

  • To assess the long-term progression of parkinsonian symptoms in patients after stopping manganese exposure.
  • To evaluate the efficacy and duration of levodopa treatment in manganese-induced parkinsonism.

Main Methods:

  • Longitudinal follow-up of six patients with chronic manganese-induced parkinsonism.
  • Clinical assessment of parkinsonian symptoms and disability scores (King's College Hospital Rating Scale).
  • Video recording analysis to confirm symptom progression, particularly gait disturbances.

Related Experiment Videos

Main Results:

  • Parkinsonian symptoms, especially gait issues like freezing and retropulsion, showed slow but significant progression over time.
  • Mean disability scores increased from 15.0 in 1987 to 28.3 in 1991 (p=0.003).
  • Levodopa provided initial improvement in three patients, but the response diminished within 2-3 years without causing dyskinesia or on-off fluctuations.

Conclusions:

  • Manganese-induced parkinsonism can lead to worsening neurological dysfunction years after manganese exposure ceases.
  • Patients with manganese-induced parkinsonism exhibit distinct responses to levodopa compared to those with idiopathic Parkinson's disease.